The immune system’s surveillance of abnormal cells is one of the reasons most people never develop lymphoma. Drugs that suppress
Dupixent is dispensed through specialty pharmacies and administered by injection every two to four weeks, which means the use record
The median delay between first symptoms and a CTCL diagnosis is measured in years, because early CTCL looks like ordinary
Federal Dupixent cases were consolidated in June 2026. The litigation is in its earliest phase, which is when claims are
Dupixent (dupilumab) is a monoclonal antibody that blocks two immune signaling proteins, interleukin-4 and interleukin-13, which drive the inflammation behind
If you have severe eczema, you know what Dupixent meant when it arrived in 2017. Skin that had itched and
When Judge Rodgers confirmed that Pfizer and plaintiffs’ leadership had reached a global settlement in principle, thousands of women asked
Two facts anchor a Depo-Provera claim: a meningioma diagnosis, which is usually well documented, and a history of DMPA use,
As of December 2025, the Depo-Provera label warns that prolonged use may increase the risk of intracranial meningioma and recommends
On June 15, 2026, the judge overseeing the Depo-Provera MDL confirmed that Pfizer and plaintiffs’ leadership had reached a global
Request a free case review. It takes about two minutes and there is no obligation.
